BioHarvest Sciences Inc. Common Stock
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BHST research report →
About the company
BioHarvest Sciences Inc. functions as a biotechnology firm with operations segmented into Nutraceuticals and Pharmaceuticals. A key innovation is its proprietary botanical synthesis platform technology, which allows for the cultivation of active ingredients found within plant enzymes or cells.
- CEO
- Ilan Sobel
- IPO
- 2021
- Employees
- 87
- HQ
- Vancouver, BC, CA
Price Chart
- Market Cap
- $49.73M
- P/E
- -5.69
- P/S
- 1.41
- P/B
- 2.83
- EV/EBITDA
- -7.03
- Div Yield
- 0.00%
- Gross Margin
- 59.50%
- Op Margin
- -16.19%
- Net Margin
- -32.54%
- ROE
- -88.01%
- ROIC
- -14.43%
- Revenue
- $34.51M · 37.00%
- Net Income
- $-11,135,000 · 13.77%
- EPS
- $-0.60 · 25.00%
- Op Income
- $-5,575,000
- FCF YoY
- -0.65%
- 52W High
- $12.80
- 52W Low
- $2.75
- 50D MA
- $3.64
- 200D MA
- $5.75
- Beta
- 1.38
- Avg Volume
- 29.80K
Get TickerSpark's AI analysis on BHST
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our BHST coverage
Recent articles, reports, and earnings notes.
No research on BHST yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BHST report →Similar companies
Peers in the same neighborhood.